BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 19875292)

  • 21. Tadalafil significantly reduces ischemia reperfusion injury in skin island flaps.
    Kayiran O; Cuzdan SS; Uysal A; Kocer U
    Indian J Plast Surg; 2013 Jan; 46(1):75-81. PubMed ID: 23960309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function in a rat model of neurogenic bladder, effect of statins and phosphodiesterase-5 inhibitors.
    Mirzaii-Dizgah I; Salmanyan B
    Eur Spine J; 2013 Dec; 22(12):2766-9. PubMed ID: 23903999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
    Küçük A; Yucel M; Erkasap N; Tosun M; Koken T; Ozkurt M; Erkasap S
    Mol Biol Rep; 2012 Oct; 39(10):9775-82. PubMed ID: 22736111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of long-term administration of tadalafil on STZ-induced diabetic rats with erectile dysfunction via a local antioxidative mechanism.
    Chen Y; Li XX; Lin HC; Qiu XF; Gao J; Dai YT; Wang R
    Asian J Androl; 2012 Jul; 14(4):616-20. PubMed ID: 22504870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil improves epicenter vascular perfusion but not hindlimb functional recovery after contusive spinal cord injury in mice.
    Myers SA; DeVries WH; Gruenthal MJ; Andres KR; Hagg T; Whittemore SR
    J Neurotrauma; 2012 Feb; 29(3):528-38. PubMed ID: 21970599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor.
    Koka S; Kukreja RC
    Mol Cell Pharmacol; 2010; 2(5):173-178. PubMed ID: 21499570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.
    Koka S; Das A; Zhu SG; Durrant D; Xi L; Kukreja RC
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1023-30. PubMed ID: 20543097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylprednisolone in spinal cord injury: the possible mechanism of action.
    Hsu CY; Dimitrijevic MR
    J Neurotrauma; 1990; 7(3):115-9. PubMed ID: 2258942
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of spinal cord injury. Current and future therapies.
    Hall ED
    Minerva Anestesiol; 1989 Mar; 55(3):63-6. PubMed ID: 2693998
    [No Abstract]   [Full Text] [Related]  

  • 30. Protective effects of edaravone on experimental spinal cord injury in rats.
    Ozgiray E; Serarslan Y; Oztürk OH; Altaş M; Aras M; Söğüt S; Yurtseven T; Oran I; Zileli M
    Pediatr Neurosurg; 2011; 47(4):254-60. PubMed ID: 22310070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats.
    Cavus G; Altas M; Aras M; Ozgür T; Serarslan Y; Yilmaz N; Sefil F; Ulutas KT
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1770-7. PubMed ID: 24992621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
    Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
    Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury.
    Topsakal C; Erol FS; Ozveren MF; Yilmaz N; Ilhan N
    Neurosurg Rev; 2002 Aug; 25(4):258-66. PubMed ID: 12172735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficiency of coenzyme Q(10) at experimental spinal cord injury].
    Kerimoğlu A; Paşaoğlu O; Kanbak G; Hanci V; Ozdemir F; Atasoy MA
    Ulus Travma Acil Cerrahi Derg; 2007 Apr; 13(2):85-93. PubMed ID: 17682949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of tadalafil on experimental spinal cord injury in rats.
    Serarslan Y; Yönden Z; Ozgiray E; Oktar S; Güven EO; Söğüt S; Yilmaz N; Yurtseven T
    J Clin Neurosci; 2010 Mar; 17(3):349-52. PubMed ID: 19875292
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.